Healthcare Professionals
Reveal LINQ™
Insertable Cardiac Monitoring System
THE WORLD’S SMALLEST, MOST ACCURATE
INSERTABLE CARDIAC MONITOR1,2
The Reveal LINQ™ Insertable Cardiac Monitor is a wireless, powerfully small insertable cardiac monitor, ideal for patients experiencing infrequent symptoms that require long-term monitoring or ongoing management.
World’s Smallest ICM1
One-third the size of a AAA battery (1.2 cc)
3-year Longevity*
Device longevity that optimizes diagnostic yield
World’s Most Accurate ICM Algorithm2
TruRhythm™ Detection inside Reveal LINQ™ ICM
1.5T & 3T MRI Conditional
No post-insertion wait time or patient positioning restrictions**
900+ PUBLISHED CLINICAL ARTICLES & ABSTRACTS
Evidence portfolio3 for RevealTM Family of ICMs
*Reference the Reveal LINQ ICM Clinician Manual for usage parameters.
**Reveal LINQ has been demonstrated to pose no known hazards in a specified MRI environment with specified conditions of use. Please see the Reveal LINQ MRI Technical Manual for more details.
DELIVERING PROVEN OUTCOMES TO ENABLE TIMELY TREATMENT
SYNCOPE
Earlier use of the Reveal LINQ™ ICM increases diagnostic yield versus standard of care, whilst reducing hospitalisations, injuries, and costs associated with Syncope patients.4,5
ESC 2018 SYNCOPE GUIDELINES
Highest recommendation and evidence for early ICM monitoring for patients with high arrhythmia risk or recurrent symptoms more than 30 days apart.4
In selected stroke patients without previously known AF, additional ECG monitoring using long-term non-invasive ECG monitors or insertable cardiac monitors should be considered, to detect AF.7
OPTIMISING RESOURCES WITHOUT COMPROMISING SAFETY AT INSERTION
REVEAL LINQ™ OUT-OF-THE-LAB PROCEDURE
Reveal LINQ™ has extensive evidence to support out-of–lab insertion being feasible, safe and efficient.9-21, 32
Moving the procedure out of lab:
- Frees up cath lab for essential procedures9,11,12,13
- Requires less specialised staff 9-13
- Improves patient flow/wait time9,13,14
Disclaimer: A controlled, head-to-head study evaluating the comparative performance of these devices has not been done.
*Based on AF episodes ≥ 2 minutes and in known AF patients. % of false positives = (1 – episode PPV). AF episodes PPV may vary between gross and patient average.
†Confirm™ Rx with SharpSense™ technology & BIOMONITOR III have no published clinical evidence showing AF episode PPV or AF sensitivity.
When compared to other ICMs, Reveal LINQ™ with TruRhythm™ Detection provides up to:22, 26, 32
Review time of 11.3 minutes per transmission, based on workflow observation in a known AF patient population. % Full-time Employee 100 Patient Clinic, 40 hours per week, 44 weeks/year.
ENABLING BEST QUALITY OF CARE WHILST DRIVING EFFICIENCIES AT EVERY STEP OF THE PATH TO DIAGNOSIS
Reveal LINQ™ Mobile Manager
Exclusive app-based programmer that simplifies ICM procedure, enabling device activation, programming and CareLink™ pre-enrollment, all from your tablet.
Reveal LINQ™ ICM with TruRhythm
World’s smallest1 and most accurate2 ICM, enabling diagnosis even for the most difficult-to detect arrhythmias.
MyCareLink™ Patient Monitor
Easy-to-use remote patient monitor with international coverage. Keeps you seamlessly connected to your patients.
BeConnected Patient Service
Phone support service dedicated to patients. Frees up clinic time as patients can contact us when they have device or monitoring questions
CareLink™ Network
Patient monitoring network that enables data-driven care decisions, quickly and easily.
FocusOn™ Monitoring and Triaging Service
Triaging Service saves time and enables better outcomes by triaging all CareLink™ data and promptly alerting your clinical team to the 20% of data that requires action.27,28
BECONNECTED PATIENT SERVICE
BeConnected is a patient support service designed to free up clinic time by directing patients to our experienced team to answer device and monitoring questions.
FOCUSON™ MONITORING AND TRIAGING SERVICE
FocusOn™ operates as a virtual extension of your team. Staffed with certified ECG device specialists and cardiologists, FocusOn™ reduces time spent reviewing non-actionable data, so that hospital clinical teams can focus on what matters.
LEARNING OBJECTIVES:
- Improving Hospital Efficiency & Safety with ICMs
- Implementing COVID-safe ICM implants: optimizing resources without compromising on safety
- Expanding remote monitoring for ICM patients: Why and how?
- How ICM technology can help driving efficiency
Implementing COVID-safe ICM implants: optimizing resources without compromising on safety - (21:32)
Dr. J. Steffel (Zurich, CH)
More information (see more)
Less information (see less)
How ICM technology can help driving efficiency - (22:21)
Ms. C. Green (Manchester, GB)
More information (see more)
Less information (see less)
Expanding remote monitoring for ICM patients: Why and how? - (18:59)
Dr. G. Molon (Negrar, IT)
More information (see more)
Less information (see less)
References
1
ICM Size Comparison Guide. Medtronic data on file. 2021.
2
ICM Published Accuracy Comparison Guide. 2021.
3
Medtronic Reveal™ Publications. Medtronic data on file. 2021.
4
Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. June 1, 2018;39(21):1883-1948.
5
Wolff P. Long Term Clinical and Economic Burden of Recurrent Unexplained Syncope and the Real World Effectiveness of Insertable Cardiac Monitors in England. Presented at ESC 2016.
6
Tsivgoulis G, et al. Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia. Stroke. Published online June 20, 2019.
7
Hindricks G, et al. “2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).” EurHeart J. 2020; 00:1-126
8
Kolominsky-Rabas PL, Heuschmann PU, Marschall D, et al. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry. Stroke. May 2006;37(5): 1179-1183.
9
Roebuck, A., et al. BJC 22 (2015).
10
BHRS Standards for insertion, follow up and explant of implantable loop recorders [ILRs] by non-medical staff, 2018.
11
Di Odoardo LAF, et al. J Cardiovasc Med. 2017;18:550-552.
12
Kipp R, et al.PACE. 2017;40:982-985.
13
Kanters, Tim A., et al. Europace (2015): euv217.
14
Wong GR, et al. Int J Cardiol. 2016;223:13-17.
15
Mittal S, et al. PACE. 2015; 38:1464-1469.
16
Beinart SC, et al. Heart Rhythm. 2016;13:5 SUPPL 1 (S15).
17
Sanders P, et al. JACC. 2017;69:354.
18
Diederichsen SZ, et al. Int J Cardiol. 2017;241:229-234.
19
Maines M et al. Europace. 2017;doi:10.1093/europace/eux187.
20
Rogers JD, et al. Heart Rhythm. 2017;14:218-224.
21
Rogers, John D., et al. Journal of Medical Economics (2020): 1-8.
22
Pürerfellner H, et al. Europace. 2018;20:f321-f328.
23
Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017.
24
Nölker G, et al. J Cardiovasc Electrophysiol. 2016;27:1403-1410.
25
Biotronik BioMonitor 2 Technical Manual. 2017.
26
Rosemas S. AF Algorithm Clinic Efficiency. Medtronic data on file. April 2020. Based on Rogers J., et al. Circulation 140: A11947, Nölker 2016, Confirm Rx™ ICM DM3500 FDA Clearance Letter. 2017, Biotronik BioMonitor™ 2 Technical Manual 2017. Pürerfellner 2018.
27
Cronin et al, 2012, Heart Rhythm, vol 9, n°12.
28
Medtronic Data on File.
29
Drak-Hernández Y et al. Effectiveness and safety of remote monitoring of patients with an implantable loop recorder. Rev Esp Cardiol (Engl Ed). 2013;66(12):943-8.
30
Nicolle E, et al. Clinic time required to manage remote monitoring of cardiac implantable electronic devices: impact of outsourcing initial data review and triage. EP Europace. 2021;23(Supplement_3):euab116-519.
31
Seiler A, et al. Clinic time required for remote and in-person management of cardiac device patients: Time and motion workflow evaluation. JMIR Cardio (Forthcoming). doi:10.2196/27720.
32
Rogers, John D., et al. Journal of Medical Economics (2020): 1-8.